Confo Therapeutics
Biotechnology; Medical; Therapeutics
Confo Therapeutics has raised €30M across 1 funding round from 2 investors, most recently a Series A round in Apr 2019. Based in Brussels, Belgium; founded 2015; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€30M
€30,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2019-04
latest 2019-04
Funding by year
EUR raised per yearConfo Therapeutics — funding by year — interactive chart.
Data table
| Confo Therapeutics — funding by year | |
|---|---|
| 2019 | €30M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-04-01 | Series A | €30M | BioGeneration Ventures,Wellington Partners | View deal → |
Related news
Similar companies
same sector, similar size- Camel-IDS€37MBelgium · Healthtech
- Icometrix€18MBelgium · Healthtech
- LynxCare€25MBelgium · Healthtech
- Imcyse€35MBelgium · Healthtech
- Celyad Oncology€29MBelgium · Healthtech
- Indigo Diabetes€38MBelgium · Healthtech
Global coverage: FundingData